*Number of shares following registration of share issue is corrected
Oslo, Norway, 15 December 2020: Reference is made to the stock exchange release
by Photocure ASA ("Photocure" or the "Company") published on 3 December 2020
regarding registration of a share capital increase following the exercise of
share options.
The issuance of 90,150 new shares has been registered with the Norwegian
Register of Business Enterprises. Following registration, the share capital of
Photocure is NOK 13,358,768 divided into *26,717,536 shares, each with a par
value of NOK 0.50. Each share represents one vote in the Company's general
meeting.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000
Email: ed@photocure.com
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, which makes
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com or www.cysview.com
All trademarks mentioned in this release are protected by law and are registered
trademarks of Photocure ASA.
This information is subject to the disclosure requirements pursuant to sections
5-12 of the Norwegian Securities Trading Act.